Innovation
3 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 50 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Developer of regenerative medicines for gastrointestinal disorders
3 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 50 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |